Collectively, this study demonstrates that morusin can inhibit proliferation, migration, invasion, and survival of melanoma cells, through activating p53-mediated pathways, therefore providing a theoretical basis for morusin to be a potential drug for the treatment of melanoma in the future. Here, TP53 is linked to melanoma.